Y-mAbs Therapeutics
YMAB
YMAB
95 hedge funds and large institutions have $374M invested in Y-mAbs Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+1
Holders Change %
+1.06%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
25
Reduced
44
Closed
18
Calls
$748K
Puts
$808K
Net Calls
-$60K
Net Calls Change
-$61K
Top Buyers
Top Sellers
| 1 |
CP
1
Caligan Partners
New York
|
$9.55M |
| 2 |
BFM
2
Boothbay Fund Management
New York
|
$5.63M |
| 3 |
3
Morgan Stanley
New York
|
$3.06M |
| 4 |
4
D.E. Shaw & Co
New York
|
$17.4M |
| 5 |
5
Los Angeles Capital Management
Los Angeles,
California
|
$2.07M |
